These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Pathogen reduction technologies: what are the concerns? AuBuchon JP Vox Sang; 2004 Jul; 87 Suppl 2():84-9. PubMed ID: 15209887 [No Abstract] [Full Text] [Related]
28. Platelet function assessed by shear-induced deposition of split triple-dose apheresis concentrates treated with pathogen reduction technologies. Picker SM; Schneider V; Gathof BS Transfusion; 2009 Jun; 49(6):1224-32. PubMed ID: 19220821 [TBL] [Abstract][Full Text] [Related]
29. Skin disinfection and bacterial contamination of blood components: be simple. Bueno JL Transfusion; 2010 Jan; 50(1):5-8. PubMed ID: 20233345 [No Abstract] [Full Text] [Related]
30. Highlights of PBTI Coimbra Conference on PRT of Plasma & Current Opinions on Pathogen Reduction Treatment of Blood Components. de Sousa G; Seghatchian J Transfus Apher Sci; 2015 Apr; 52(2):228-32. PubMed ID: 25770045 [TBL] [Abstract][Full Text] [Related]
31. Successful removal of Chlamydia pneumoniae from plateletpheresis products collected using automated leukoreduction hemapheresis techniques. Webley W; Stuart E; Cirino F; Cahill F; Stec T; Andrzejewski C J Clin Apher; 2006 Oct; 21(3):195-201. PubMed ID: 16570261 [TBL] [Abstract][Full Text] [Related]
32. Inactivation of human white blood cells in platelet products after pathogen reduction technology treatment in comparison to gamma irradiation. Fast LD; DiLeone G; Marschner S Transfusion; 2011 Jul; 51(7):1397-404. PubMed ID: 21155832 [TBL] [Abstract][Full Text] [Related]
33. Balancing evidence and public opinion in health technology assessments: the case of leukoreduction. Cleemput I; Leys M; Ramaekers D; Bonneux L Int J Technol Assess Health Care; 2006; 22(4):403-7. PubMed ID: 16984672 [TBL] [Abstract][Full Text] [Related]
34. Current trends in blood component therapy: the evolution of a safer, more effective product. Baranowski L J Intraven Nurs; 1992; 15(3):136-51. PubMed ID: 1608013 [TBL] [Abstract][Full Text] [Related]
36. Bacterial risk reduction by improved donor arm disinfection, diversion and bacterial screening. McDonald CP Transfus Med; 2006 Dec; 16(6):381-96. PubMed ID: 17163869 [TBL] [Abstract][Full Text] [Related]
37. Iron and blood donation- an under-recognised safety issue. Farrugia A Dev Biol (Basel); 2007; 127():137-46. PubMed ID: 17486886 [TBL] [Abstract][Full Text] [Related]
38. Blood banking and transfusion medicine for the nephrologist. Wehrli G Semin Dial; 2012; 25(2):114-8. PubMed ID: 22276991 [TBL] [Abstract][Full Text] [Related]
39. Experience with routine total nonfasting blood cholesterol screening of volunteer blood and component donors. Eason S; Goudar S; Centilli J; Sayers M Transfusion; 2011 Apr; 51(4):731-6. PubMed ID: 20977488 [TBL] [Abstract][Full Text] [Related]